Drug recall · December 28, 2016
Bupivacaine Hydrochloride Inj recall
Why: Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
- Lots / codes
Lot # 59064DK, Exp. 11/17
- Quantity
- 143,250 vials
- Company
- Hospira Inc., A Pfizer Company, Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- August 4, 2016 · Voluntary: Firm initiated
- Classified
- December 22, 2016
- Reported
- December 28, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.